Old Web
English
Sign In
Acemap
>
authorDetail
>
Marinus H. J. van Oers
Marinus H. J. van Oers
Immunology
Chronic lymphocytic leukemia
Medicine
Lymphoma
Neutropenia
3
Papers
111
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Interim Analysis Of Dose-Escalation Stage Of a Phase 1b Study Evaluating Safety and Pharmacology Of GS-9820, a Second-Generation, Selective, PI3Kd-Inhibitor in Recurrent Lymphoid Malignancies
2013
Blood
Arnon P. Kater
Sanne H. Tonino
Marie José Kersten
Anton Hagenbeek
Marjolein Spiering
Marinus H. J. van Oers
Yan Xin
Srinivasan Ramanathan
María Aiello
Susie Jun
Show All
Source
Cite
Save
Citations (12)
Immunochemotherapy with Low-Dose Subcutaneous Alemtuzumab (A) Plus Oral Fludarabine and Cyclophosphamide (FC) Is Safe and Induces More and Deeper Complete Remissions in Untreated Patients with High-Risk Chronic Lymphocytic Leukemia (CLL) Than Chemotherapy with FC Alone. An Early Analysis of the Randomized Phase-III HOVON68 CLL Trial
2011
Blood
Christian H. Geisler
Mars Mb van t Veer
Wim L. J. van Putten
Jesper Jurlander
Jan Walewski
Geir E. Tjonnfjord
Maija Itälä-Remes
Eva Kimby
Tomas Kozak
Aaron Polliack
Shulamiet Wittebol
Fokje M. Spoelstra
Marinus H. J. van Oers
Show All
Source
Cite
Save
Citations (17)
Plasma tumor necrosis factor-a (TNF-a) levels in Gaucher disease
1996
Biochimica et Biophysica Acta
Helen Michelakakis
Cleopatra Spanou
Anastasia Kondyli
Evagelia Dimitriou
Sonja van Weely
Carla E. M. Hollak
Marinus H. J. van Oers
Johannes M. F. G. Aerts
Show All
Source
Cite
Save
Citations (82)
1